Neurogene Inc.
NGNE
$19.95
$0.713.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.95M | -22.02M | -22.65M | -19.51M | -20.22M |
| Total Depreciation and Amortization | 776.00K | 767.00K | 762.00K | 798.00K | 807.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.93M | 2.19M | 2.53M | 2.12M | 1.28M |
| Change in Net Operating Assets | -1.27M | -401.00K | -1.41M | -896.00K | 2.56M |
| Cash from Operations | -19.51M | -19.46M | -20.77M | -17.50M | -15.56M |
| Capital Expenditure | -127.00K | -148.00K | -780.00K | -116.00K | -167.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.12M | 7.60M | -44.27M | -102.50M | -28.80M |
| Cash from Investing | 21.99M | 7.45M | -45.05M | -102.62M | -28.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.00K | -14.00K | -15.00K | -13.00K | -12.00K |
| Issuance of Common Stock | 9.89M | 68.00K | 19.00K | 190.08M | 143.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -166.00K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 9.71M | 54.00K | 4.00K | 190.07M | 131.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.19M | -11.96M | -65.82M | 69.95M | -44.40M |